Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCT650C in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
NCT07244510Phase 2Recruiting
- Sponsor
- Sinocelltech Group Limited
- Start
- Dec 2025
- Primary completion
- Mar 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of SCT650C in hidradenitis suppurativa (HS), sponsored by Sinocelltech Group Limited. Started Dec 2025; status: recruiting.
02
Drugs
SCT650C
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NCT07244510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07244510.